Clinical trial Recruiting at 1 site Interventional Ages 18 to 50 Women only

Evaluating blood loss after cesarean delivery using ultrasound

Official title: Ultrasound Use Compared With Standard Care for Diagnosis of Blood Loss After Cesarean Delivery: A Randomized Controlled Trial

Run by Holy Family Hospital, Nazareth, Israel · NCT06963047 · Data updated 2026-11-12

This study is trying to see if using ultrasound can help new moms find out if they have anemia from blood loss after a cesarean delivery faster than regular lab tests.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexWomen only
Enrollment276 (estimated)
SponsorHoly Family Hospital, Nazareth, Israel
Academic / other
Locations1 site (Nazareth, North)
StatusRecruiting
StartedMay 8, 2025
Main results expectedMay 1, 2027
Study endsJune 1, 2027
Registry record updatedJune 16, 2026
Trial IDNCT06963047 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women over 18 who have delivered via cesarean section and can provide informed consent.

Probably not a fit

Patients who may not benefit include those with preoperative coagulation disorders or those requiring intensive care post-surgery.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines the effectiveness of ultrasound in diagnosing postpartum anemia due to blood loss after cesarean delivery compared to standard care. It focuses on the critical period following delivery, where timely diagnosis and treatment of anemia can significantly impact maternal health and mother-infant bonding. The study aims to determine if ultrasound can provide earlier detection of anemia than traditional laboratory tests, which may not reflect the lowest hemoglobin levels until 48-72 hours postpartum. By addressing postpartum hemorrhage and anemia, the study seeks to improve maternal outcomes and reduce associated risks.

Why it matters

Potential benefit: If successful, this approach could lead to earlier diagnosis and treatment of postpartum anemia, improving maternal health and reducing complications.

How similar studies have gone: While the approach of using ultrasound for this purpose is innovative, similar studies have not been widely reported, indicating this may be a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women who delivered by a cesarean section.
* Age over 18.
* Fluent in Hebrew or Arabic.
* Signed informed consent form.

Exclusion Criteria:

* Lack of consent or inability to provide informed consent.
* Inability to perform a post-surgical ultrasound, such as post-surgery hospitalization in the intensive care unit.
* Women with preoperative coagulation disorders.
* Women whose clinical condition requires a post-cesarean ultrasound examination.

Where it's running

  • Holy family hospital
    Nazareth, North, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.